Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576394 · ClinicalTrials.gov registry record · Phase 1
Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients
A Phase 1 study, sponsored by American Heart Association.
- Completed
- Registry status
- Phase 1
- Development phase
- 108
- Enrollment target
NCT00576394 is a Phase 1 study that has completed, run by American Heart Association. The registered enrollment target is 108 participants.
The verdict
NCT00576394, a Phase 1 study, has completed, sponsored by American Heart Association.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 108 participants
- Enrollment target
Study Summary
entGlycemic control has been found to improve clinical outcomes following Coronary Bypass Surgery. This study tests the hypothesis that obtaining tighter glycemic control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve outcomes.
Interventions
- DRUG Insulin
- DRUG IV Insulin drip
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2006-10 |
| Est. Completion | 2015-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00576394
The ClinicalTrials.gov registry entry for NCT00576394 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Heart Association, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Insulin is the first listed.
NCT00576394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00576394 about?
NCT00576394 is a clinical study titled "Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients". entGlycemic control has been found to improve clinical outcomes following Coronary Bypass Surgery. This study tests the hypothesis that obtaining tighter glycemic control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve outcomes.
What is the current status of trial NCT00576394?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 108 participants. The study started on 2006-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00576394?
The interventions under investigation include: Insulin (DRUG), IV Insulin drip (DRUG).
Who is sponsoring clinical trial NCT00576394?
This trial is sponsored by American Heart Association, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.